Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Hay, A. Veitch, M. Smith, R. Cousins, J. Gaylor (2000)
Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver.Artificial organs, 24 4
J. Piret, C. Cooney (1990)
Mammalian cell and protein distributions in ultrafiltration hollow fiber bioreactorsBiotechnology and Bioengineering, 36
R. McCuskey (2008)
The Hepatic Microvascular System in Health and Its Response to ToxicantsThe Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, 291
A. Wigg, R. Padbury (2005)
Liver support systems: Promise and realityJournal of Gastroenterology and Hepatology, 20
Jesse Sullivan, Jason Gordon, T. Bou-akl, H. Matthew, A. Palmer (2007)
Enhanced Oxygen Delivery to Primary Hepatocytes within a Hollow Fiber Bioreactor Facilitated via Hemoglobin-Based Oxygen CarriersArtificial Cells, Blood Substitutes, and Biotechnology, 35
I. Sauer, D. Kardassis, K. Zeillinger, A. Pascher, A. Gruenwald, G. Pless, M. Irgang, M. Kraemer, G. Puhl, J. Frank, A. Müller, T. Steinmüller, J. Denner, P. Neuhaus, J. Gerlach, J. Gerlach (2003)
Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cellsXenotransplantation, 10
P. Hay, A. Veitch, J. Gaylor (2001)
Oxygen transfer in a convection-enhanced hollow fiber bioartificial liver.Artificial organs, 25 2
J. Brotherton, P. Chau (1996)
Modeling of Axial‐Flow Hollow Fiber Cell Culture BioreactorsBiotechnology Progress, 12
J. Rozga, Frederick Williams, Man-soo Ro, D. Neuzil, T. Giorgio, G. Backfisch, A. Moscioni, Raymond Hakim, A. Demetriou (1993)
Development of a bioartificial liver: Properties and function of a hollow‐fiber module inoculated with liver cellsHepatology, 17
Vivek Dixit, Gary Gitnick (2003)
The bioartificial liver: state-of-the-art.The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 582
minimum allowable number of fibers according to the cell number constraint
G. Pless, I. Sauer (2005)
Bioartificial liver: current status.Transplantation proceedings, 37 9
J. Gerlach, K. Zeilinger, John Ii (2008)
Bioartificial liver systems: why, what, whither?Regenerative medicine, 3 4
A. Tilles, H. Baskaran, Partha Roy, M. Yarmush, M. Toner (2001)
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor.Biotechnology and bioengineering, 73 5
A. Demetriou, Robert Brown, R. Busuttil, J. Fair, B. McGuire, P. Rosenthal, J. Esch, J. Lerut, S. Nyberg, M. Salizzoni, E. Fagan, B. Hemptinne, C. Broelsch, M. Muraca, J. Salmerón, J. Rabkin, H. Metselaar, D. Pratt, M. Mata, L. McChesney, G. Everson, P. Lavin, A. Stevens, Z. Pitkin, B. Solomon (2004)
Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver FailureAnnals of Surgery, 239
N cell number of cells in the BAL
J. Woodley, N. Titchener-Hooker (1996)
The use of windows of operation as a bioprocess design toolBioprocess Engineering, 14
J. Piret, C. Cooney (1991)
Model of oxygen transport limitations in hollow fiber bioreactorsBiotechnology and Bioengineering, 37
M. Kerkhove, R. Hoekstra, R. Chamuleau, T. Gulik (2004)
Clinical Application of Bioartificial Liver Support SystemsAnnals of Surgery, 240
Philip Drazin (2018)
Fluid mechanicsPhysics Education, 22
A. Krogh (1919)
The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissueThe Journal of Physiology, 52
J. Stange, S. Mitzner, T. Risler, C. Erley, W. Lauchart, H. Goehl, S. Klammt, P. Peszynski, J. Freytag, H. Hickstein, M. Löhr, S. Liebe, W. Schareck, U. Hopt, R. Schmidt (1999)
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.Artificial organs, 23 4
T. Mckenzie, J. Lillegard, S. Nyberg (2008)
Artificial and bioartificial liver support.Seminars in liver disease, 28 2
Y. Zhou, N. Titchener-Hooker (1999)
Visualizing integrated bioprocess designs through "windows of operation".Biotechnology and bioengineering, 65 5
R. Willaert, A. Smets, L. Vuyst (1999)
Mass transfer limitations in diffusion-limited isotropic hollow fiber bioreactorsBiotechnology Techniques, 13
S. Nyberg, R. Remmel, H. Mann, M. Peshwa, Wei-Shou Hu, F. Cerra (1994)
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.Annals of surgery, 220 1
S. Rave, H. Tilanus, J. Linden, R. Man, B. Berg, W. Hop, J. Ijzermans, P. Zondervan, H. Metselaar (2002)
The importance of orthotopic liver transplantation in acute hepatic failureTransplant International, 15
S. Diekmann, A. Bader, S. Schmitmeier (2006)
Present and Future Developments in Hepatic Tissue Engineering for Liver Support SystemsCytotechnology, 50
H. Ye, D. Das, J. Triffitt, Z. Cui (2006)
Modelling nutrient transport in hollow fibre membrane bioreactors for growing three-dimensional bone tissueJournal of Membrane Science, 272
H. Groot, A. Littauer, T. Noll (1988)
Metabolic and Pathological Aspects of Hypoxia in Liver Cells
P. Peszynski, S. Klammt, E. Peters, S. Mitzner, J. Stange, R. Schmidt (2002)
Albumin dialysis: single pass vs. recirculation (MARS).Liver, 22 Suppl 2
Bioartificial livers (BALs) are a potentially effective countermeasure against liver failure, particularly in cases of acute or fulminant liver failure. It is hoped these devices can sustain a patient's liver function until recovery or transplant. However, no large‐scale clinical trial has yet proven that BALs are particularly effective and evidently design issues remain to be addressed. One aspect of BAL design that must be considered is the mass transfer of adequate oxygen to the hepatocytes within the device. We present here a mathematical modeling approach to oxygen mass transport in a BAL. A mathematical model based upon Krogh cylinders is outlined to describe a diffusion‐limited hollow fiber bioreactor. In addition, operating constraints are defined on the system—cells should not experience hypoxia and the cell population should be of adequate size. By combining modeling results with these operating constraints and presenting the results graphically, “operating region” charts can be constructed for the hollow fiber BAL (HF‐BAL). The effects of varying various operating parameters on the BAL are then established. It is found that smaller radii and short, thin walled fibers are generally advantageous while cell populations in excess of 10 billion could be supported in the BAL with a plasma flow rate of 200 mL/min. For fibers of intermediate length and lumen radius, the minimum number of fibers required to produce a viable design ranges approximately from 7,000–10,000. In theory, this may be enough to support patients with failing livers. Biotechnol. Bioeng. 2010;106: 980–988. © 2010 Wiley Periodicals, Inc.
Biotechnology and Bioengineering – Wiley
Published: Aug 15, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.